XML 44 R25.htm IDEA: XBRL DOCUMENT

Share-based Compensation (Tables)

9 Months Ended

Dec. 31, 2020

Summary of share-based compensation expense for options

The following table summarizes the share-based compensation expense for SSARs, restricted and performance grants included in the condensed consolidated statements of operations:

	Three Months Ended December 31,				Nine Months Ended December 31,
(In thousands)	2020		2019		2020		2019
Product development	$	3,362	$	639	$	3,773	$	1,579
Sales and marketing		666		104		735		217
General and administrative		2,602		586		4,804		1,360
Total share-based compensation expense	$	6,630	$	1,329	$	9,312	$	3,156

Activity related SSARs award

The following table summarizes the activity during the nine months ended December 31, 2020 for SSARs awarded under the 2020 and 2016 Plans:

	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)
Outstanding at April 1, 2020		1,644,888		$	21.07
Granted		2,234,858			20.02
Exercised		(80,255	)		11.93
Forfeited		(68,201	)		19.79
Expired		(2,118	)		14.22
Outstanding at December 31, 2020		3,729,172		$	20.66		5.5	$	66,069
Exercisable at December 31, 2020		995,713		$	14.73		3.5	$	23,544
Vested and expected to vest at December 31, 2020		3,729,172		$	20.66		5.5	$	66,069

The following table summarizes the activity during the nine months ended December 31, 2020 for restricted shares awarded under the 2020 and 2016 Plans:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2020		178,462		$	19.89
Granted		56,527			39.63
Forfeited		(30,980	)		20.65
Outstanding at December 31, 2020		204,009		$	25.24

Performance shares awarded

The following table summarizes the activity during the nine months ended December 31, 2020 for the performance shares awarded under the 2016 Plan:

	Number of Shares
Outstanding at April 1, 2020		30,120
Granted		—
Vested		(6,714	)
Forfeited		(23,406	)
Outstanding at December 31, 2020		—